Home › Why This Small Victory Against Short Sellers Might Be a Big Deal for Biotech Companies
 

Keywords :   


Why This Small Victory Against Short Sellers Might Be a Big Deal for Biotech Companies

2015-08-25 18:56:08| Biotech - Topix.net

Acorda Therapeutics, a small New York-based drug maker, just won a round in a rather obscure patent fight with hedge fund manager Kyle Bass. You haven't been following this? The case matters a great deal to the biotech industry, and the implications may stretch far beyond.

Tags: for small big short

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Hurricane Beryl Graphics
05.07Hurricane Beryl Public Advisory Number 25A
05.07Summary for Hurricane Beryl (AT2/AL022024)
05.07Amazon at 30: What next for 'The Everything Company'?
05.07Atlantic Tropical Weather Outlook
05.07Could the 'flying piano' help transform air cargo?
05.07Eastern North Pacific Tropical Weather Outlook
04.07Hurricane Beryl Graphics
More »